Search clinical trials for: Avodart

Total 50 results

Bio-innova Co., Ltd

Not yet recruiting

Dutasteride Soft Capsule 0.5 mg Relative to Avodart 0.5 mg Soft Capsule

Healthy Subjects
Radboud University Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development

Recruiting

Phase II Dutasteride in Combination With CAB vs CAB in SDC (DUCT)

Salivary Duct Carcinoma

Netherlands
University of Chicago

Active, not recruiting

Feasibility of Hormones and Radiation for Intermediate or High Risk Prostate Cancer

Prostate Cancer

United States
Dongkook Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety of DKF-313 in Patients With Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

Korea, Republic of
NorthShore University HealthSystem
Northwestern University; University of Chicago

Completed

Effect of Dutasteride on Androgen-Response Gene Expression in Patients With Advanced Prostate Cancer

Prostate Cancer

United States
UConn Health
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Active, not recruiting

Dutasteride Treatment for Reducing Heavy Drinking in AUD: Predictors of Efficacy

Alcohol Use Disorder

United States
CHU de Quebec-Universite Laval
GlaxoSmithKline

Completed

Efficacy and Toxicity of Bicalutamide and Dutasteride vs. Standard Care for Prostate Cytoreduction for Brachytherapy

Lower Urinary Tract Symptoms | Erectile Dysfunction | Prostate Cancer

Canada
Dongkook Pharmaceutical Co., Ltd.

Completed

Safety and Pharmacokinetic Characteristics of DKF-313

Healthy | Benign Prostate Hyperplasia

Korea, Republic of
Addpharma Inc.

Completed

To Evaluate the Pharmacokinetics and Safety of AD-208

Androgenetic Alopecia

Korea, Republic of
University of Illinois at Chicago
GlaxoSmithKline

Completed

Long-term Effects of Dutasteride on Architectural and Nuclear Morphometric Features of Benign Prostate Tissue

Benign Prostate Tissue

United States
University of Washington

Withdrawn

ITT-5 Mechanisms of Spermatogenesis in Man (ITT-5)

Gonadotropin Deficiency

United States
UConn Health
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Dutasteride Treatment for the Reduction of Heavy Drinking in Men

Alcohol Dependence | Alcoholism | Alcohol Abuse

United States
Dana-Farber Cancer Institute
Massachusetts General Hospital; GlaxoSmithKline; Beth Israel Deaconess Medical... and other collaborators

Terminated

Ketoconazole, Hydrocortisone, Dutasteride and Lapatinib (KHAD-L) in Prostate Cancer (KHLAD)

Prostate Cancer

United States
GlaxoSmithKline

Completed

This Will be an Open-label, Three-period, Fixed-sequence Study to Evaluate the Drug-drug Interaction, Pharmacokinetics and Safety of Dutasteride and Tamsulosin When Administered Alone and In-combination in Chinese Healthy Male Volunteers. The Study Will Last Approximately Eleven Weeks. Blood Samples

Prostatic Hyperplasia

China
GlaxoSmithKline

Completed

AVODART® Alopecia Post-marketing Surveillance (PMS) (AVODART®PMS)

Alopecia

Korea, Republic of
Unita Complessa di Ostetricia e Ginecologia
Schering-Plough

Completed

Testosterone and Its Metabolites in GID

Transsexualism

Italy
Mary-Ellen Taplin, MD

Completed

Abiraterone Acetate Combined With Dutasteride for Metastatic Castrate Resistant Prostate Cancer

Prostate Cancer

United States
GlaxoSmithKline

Completed

Observational AVODART (Dutasteride) Study In Benign Prostatic Hyperplasia Subjects - OASIS

Prostatic Hyperplasia

United Kingdom
GlaxoSmithKline

Completed

A Study To Compare Giving AVODART And FLOMAX Together Or In A Combination Capsule In The Fed And Fasted State

Prostatic Hyperplasia

United States
GlaxoSmithKline

Completed

AVODART(Dutasteride) Post-marketing Surveillance(PMS) (AVO PMS)

Prostatic Hyperplasia | Benign Prostatic Hyperplasia

Korea, Republic of
GlaxoSmithKline

Completed

Bioequivalence - Duodart Against Avodart & Omnic

Prostatic Hyperplasia

Russian Federation
GlaxoSmithKline

Completed

Demonstrating the Clinical and Economic Benefit of 5 Alpha Reductase Inhibitor Adherence in Benign Prostatic Hyperplasia

Prostatic Hyperplasia
GlaxoSmithKline

Completed

Benefits of Adherence to 5-alpha Reductase Inhibitor Treatment in Men With Enlarged Prostate: An Assessment of Medicare and Medicaid Patients Using the MarketScan Database

Prostatic Hyperplasia
GlaxoSmithKline

Completed

Establishing Predictors of Enlarged Prostate Treatment Adherence: Linking Symptom Improvement to Adherence

Prostatic Hyperplasia
GlaxoSmithKline

Completed

Clinical and Economic Outcomes of Patients Utilizing Combination Therapy for Enlarged Prostates: A Henry Ford Database Assessment

Prostatic Hyperplasia
GlaxoSmithKline

Completed

Clinical Progression and Costs in Benign Prostatic Hyperplasia Patients Treated With Early Versus Delayed Combination Therapy

Benign Prostatic Hyperplasia
UConn Health
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Dutasteride for the Reduction of Alcohol Use in Male Drinkers

Alcohol Dependence | Alcoholism | Alcohol Abuse

United States
GlaxoSmithKline

Completed

Assessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cancer In Men

Neoplasms, Prostate

United States, Canada
University of Colorado, Denver
GlaxoSmithKline

Terminated

Role of Dutasteride in Patients Undergoing 3D Mapping Biopsy in Early Stage Prostate Cancer

Prostate Cancer

United States
Northwestern University
GlaxoSmithKline

Terminated

A Clinical Trial Comparing Laser TURP With and Without Dutasteride.

Benign Prostatic Hyperplasia
Toni Choueiri, MD

Withdrawn

STA-9090 in Castration-Resistant Prostate Cancer With Assessment of Androgen Receptor Pathway Signaling

Adenocarcinoma of the Prostate

United States
Beth Israel Deaconess Medical Center
M.D. Anderson Cancer Center; Massachusetts General Hospital; Sunnybrook Health... and other collaborators

Completed

Ketoconazole, Hydrocortisone and Dutasteride in Asymptomatic Hormone Refractory Prostate Cancer (KHAD)

Prostate Cancer

United States, Canada
Kenneth Pienta, MD
Prostate Cancer Foundation Norway

Withdrawn

A Phase II Neoadjuvant Study of Enzalutamide, Abiraterone Acetate, Dutasteride and Degarelix in Men With Localized Prostate Cancer Pre-prostatectomy

Prostate Cancer | Localized Prostate Cancer

United States
Bay State Clinical Trials, Inc.
GlaxoSmithKline

Completed

Study Assessing The Efficacy And Safety Of Avodart (Dutasteride) At Improving Urinary Symptoms In Men With Prostate Cancer Who Are Undergoing Seed Implantation

Prostate Cancer

United States
University of Washington
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

ITT4 Intratesticular Hormonal Milieu in Man (ITT4) (ITT4)

Healthy Males

United States
University of California, San Francisco

Completed

MRI and Magnetic Resonance Spectroscopy Imaging in Patients Receiving Dutasteride for Benign Prostatic Hypertrophy and Low-Risk Prostate Cancer

Prostate Cancer | Nonmalignant Neoplasm

United States
University of Washington
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

PROS-1-Male Hormonal Contraceptive Regimens on Prostate Tissue (PROS-1)

Healthy

United States
The Miriam Hospital
GlaxoSmithKline

Completed

Efficacy Study for Use of Dutasteride (Avodart) With Testosterone Replacement (DUT/T)

Hypogonadism

United States
North Florida/South Georgia Veterans Health System

Completed

Dutasteride After Failure of Finasteride In the Management of Symptomatic Prostatic Enlargement/Hypertrophy (BPE/H)

Benign Prostatic Hypertrophy
GlaxoSmithKline

Completed

Establishing the Benefits of Adherence to Enlarged Prostate Treatment: A Validation Study Linking Adherence to Outcomes Using the Market Scan Database

Prostatic Hyperplasia
UConn Health
National Institute on Alcohol Abuse and Alcoholism (NIAAA); National Institutes...

Completed

Pharmacogenetics of Alcohol: Treatment Implications

Alcoholism | Alcohol Related Disorders | Alcohol Abuse

United States
GlaxoSmithKline

Completed

ARTS - AVODART After Radical Therapy For Prostate Cancer Study (ARTS)

Neoplasms, Prostate | Prostate Cancer After a Radical Treatment

Spain, Estonia, Netherlands, United Kingdom, Germany, Finland, France, Russian Federation, Sweden
Sunnybrook Health Sciences Centre
Toronto Sunnybrook Regional Cancer Centre

Completed

Response of Patients on Surveillance for Prostate Cancer to Dutasteride

Prostate Cancer

Canada
National Institute of Neurological Disorders and...

Completed

Dutasteride to Treat Spinal and Bulbar Muscular Atrophy (SBMA)

Spinal and Bulbar Muscular Atrophy | Kennedy's Disease

United States
UConn Health
National Institute on Alcohol Abuse and Alcoholism (NIAAA); National Institutes...

Completed

Pharmacokinetic Study of Single Dose Dutasteride in Healthy Subjects

Alcoholism | Alcohol Related Disorders | Alcohol Abuse

United States
Samsung Medical Center
GlaxoSmithKline

Completed

Effect of Dutasteride on Bladder Wall Hypertrophy in Patients With Benign Prostatic Obstruction

Benign Prostatic Hyperplasia

Korea, Republic of
GlaxoSmithKline

Completed

Pharmacovigilance Study To Evaluate Safety Of AVODART In Subjects With Benign Prostate Hyperplasia

Benign Prostatic Hyperplasia
University of Washington
GlaxoSmithKline

Completed

Oral Androgens in Man-4: (Short Title: Oral T-4)

Contraception

United States
University of Washington
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Oral Androgens in Man-3 (ORAL T-3) Pharmacokinetics of Oral Testosterone

Contraception | Hypogonadism

United States
Urologic Consultants of Southeastern PA

Unknown

A Study to Determine the Improvement of the Symptoms of Benign Prostatic Hyperplasia (BPH) When Switching Subjects From Proscar to Avodart

Benign Prostatic Hyperplasia

United States

Search clinical trials for: Avodart

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Serbia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations